Search

everythinglearnresearchcommunity

for

Search:↓

New compounds were made that effectively block a specific enzyme related to androgen conditions.

Glibenclamide slows breast cancer cell growth by stopping cell division.

Antihepcidin antibodies may treat inflammation-induced anemia by improving iron metabolism.

JAK inhibitors are effective and generally safe for treating alopecia areata, but monitoring for side effects is important.

Continuous glucose monitoring and GLP-1 receptor agonists improve diabetes management, but personalized care and education are crucial.

Effective, well-tolerated, and affordable treatments are needed for recurrent ischemic priapism.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

TRIV-509 quickly improves skin barrier and cell health in atopic dermatitis.

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.

Patients with acne and insulin resistance have different blood metabolites compared to those with only acne, which could help in diagnosis and treatment.

GI197111X is best dissolved in Capmul MCM for trials.

Dutasteride potentially improves cell survival and reduces retinal damage in retinitis pigmentosa.

New steroids were patented as effective for treating acne, hair loss, and other conditions related to hormones.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

Some patients receiving pegylated interferon alfa injections developed skin necrosis, requiring treatment adjustments or discontinuation.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

Compounds from Pterocarpus indicus may help treat benign prostatic hyperplasia by stopping cell growth.

Tyrosine kinase inhibitors effectively treat cancers but often cause skin and other side effects.

Individualized treatments may help manage Dercum's disease symptoms.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

JAK inhibitors effectively treat skin conditions and topical forms are safer.

Researchers developed a model to predict how well certain compounds can block an enzyme related to hair loss and prostate issues, suggesting a 50 mg dose of finasteride might be effective based on lab and body data.

Tyrosine kinase inhibitors show promise in treating some skin diseases but their definitive role in dermatology is still unclear.

5-alpha reductase inhibitors may increase depression risk by 31%, but results vary based on comparison groups.